Related Experiment Videos
[Prolactin in connective tissue diseases]
Jolanta Parada-Turska1, Bozena Targońska-Stepniak, Maria Majdan
1Katedra i Klinika Reumatologii i Układowych Chorób Tkanki Łacznej Akademii Medycznej im. prof. Feliksa Skubiszewskiego w Lublinie.
Postepy Higieny I Medycyny Doswiadczalnej (Online)
|May 23, 2006
Summary
Prolactin (PRL) significantly impacts the immune system and rheumatic diseases like systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). This review explores PRL
Area of Science:
- Endocrinology and Immunology
- Rheumatology and Autoimmunity
Context:
- The intricate relationship between the endocrine and immune systems is increasingly recognized in autoimmune pathogenesis.
- Prolactin (PRL), a pituitary hormone, exhibits immunomodulatory functions with implications for rheumatic diseases.
Purpose:
- To elucidate the role of prolactin (PRL) in the pathogenesis of various connective tissue diseases.
- To discuss the mechanisms of hyperprolactinemia in systemic lupus erythematosus (SLE) and its clinical correlations.
- To review the therapeutic potential of dopamine receptor agonists in managing connective tissue diseases.
Summary:
- This paper details the interactions between prolactin and the immune system, focusing on its contribution to rheumatic conditions such as SLE, rheumatoid arthritis (RA), Sjögren's syndrome, and systemic sclerosis.
- It examines the causes of elevated prolactin levels (hyperprolactinemia) in SLE patients, linking it to disease activity and organ damage.
- The therapeutic use of dopamine receptor agonists for these conditions is also explored.
Impact:
- Provides a comprehensive overview of prolactin's involvement in rheumatic disease pathogenesis.
- Highlights the clinical significance of hyperprolactinemia in SLE management.
- Informs potential therapeutic strategies targeting the prolactin pathway in autoimmune diseases.